Biopharma and Health Related News

Living medicines: Accessing the cancer-fighting power within your body

This story is brought to you by Ginkgo Bioworks, a company developing new organisms that replace technology with biology, and Twist Bioscience, a company making DNA for medicine, agriculture, industrial chemicals and data storage. Chemotherapy is the stone age of [...]

Bactevo Announces Addition to Scientific Advisory Board and Company Name Change

August 14, 2018 03:00 AM Eastern Daylight Time CAMBRIDGE, England--(BUSINESS WIRE)--Bactevo Ltd. announced today that Professor Pietro Lio of the Computer Laboratory in Cambridge University has joined its Scientific Advisory Board. Pietro brings a wealth of skills from the [...]

Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria

– Preclinical studies published in Nature Biotechnology identify key biomarkers of SYNB1618 activity in healthy animals and disease models – – Clinical data expected in 2018 from healthy volunteer cohorts of ongoing Phase 1/ 2a study of SYNB1618; data [...]

Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies

MENLO PARK, Calif., and SAN DIEGO — August 7, 2018 — Teneobio, Inc., a next generation multi-specific antibody therapeutics company, and Poseida Therapeutics, Inc., a San Diego-based clinical-stage company translating best-in-class gene engineering technologies into lifesaving cell therapies, announced today [...]

NSW Health Funds Indee Labs’ First Preclinical Study Into Gene-Modified Cell Therapy Manufacturing for Blood Cancer

This preclinical study will pave the way for biopharmaceutical companies to transition away from using viruses. The aim is to enable gene-modified cell therapy manufacturing with open source biology to provide patients with improved access to curative therapies for blood [...]

Azitra Awarded NIH SBIR Grant to Develop Microbiome-based Therapeutic for Netherton Syndrome

FARMINGTON, CT, August 1, 2018 – Azitra, Inc., today announced that the company has been awarded a $225,000 Small Business Innovation Research (SBIR) Phase I award (R43AR073562) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of [...]